Table 1.
Characteristics of the Study Sample (Modena HIV Metabolic Clinic)
| Whole sample | SCA | Non-SCA | |
|---|---|---|---|
| Sample size (n [%]) | 103 [100] | 40 [38.8] | 63 [61.2] |
| Age (mean ± SD) | 56.4 ± 6.1 | 57.0 ± 6.7 | 56.0 ± 5.7 |
| Sex (female; n [%]) | 28 [27.2] | 13 [33] | 15 [24] |
| Nadir CD4 (mean ± SD) | 178.9 ± 141.3 | 179.7 ± 129.7 | 178.1 ± 149.2 |
| Current CD4 (mean ± SD) | 611.0 ± 212.9 | 604.2 ± 171.1 | 615.4 ± 237.3 |
| Functional impairmenta | 0 | 0 | 0 |
| Number of HANAb conditions | 1.2 ± 1.0 | 0.9 ± 1.0 | 1.3 ± 1.0* |
| Frailty index (mean ± SD) | 0.26 ± 0.10 | 0.23 ± 0.09 | 0.28 ± 0.10* |
| Multi-morbidity (n [%]) | 34 [33.0] | 9 [22.5] | 25 [39.7]* |
| Successful cognitive aging (n [%]) | 40 [38.8] | — | — |
| Cardiovascular disease (n [%]) | 9 [8.7] | 2 [5.0] | 7 [11.1] |
| Hypertension (n [%]) | 57 [55.3] | 17 [42.5] | 40 [63.5]* |
| Diabetes (type II; n [%]) | 16 [15.5] | 5 [12.5] | 11 [17.5] |
| End-stage kidney failure (n [%]) | 2 [1.9] | 2 [5.0] | 0 |
| Liver cirrhosis (n [%]) | 5 [4.9] | 2 [5.0] | 3 [4.8] |
| Chronic obstructive pulmonary disease (n [%]) | 7 [6.8] | 3 [7.5] | 4 [6.3] |
| Osteoporosis (n [%]) | 24 [23.3] | 6 [15.0] | 18 [28.6] |
| Cancer (any; n [%]) | 1 [1.0] | 0 | 1 [1.6] |
a
As measured by difficulty with instrumental activities of daily living.
b
HIV-Associated Non-AIDS.
*
p < 0.05.
SCA, successful cognitive aging; SD, standard deviation.